We are delighted at Health Analytical Solutions Ltd to have successfully supported KCI an Acelity company achieve National Institute for Health and Care Excellence (NICE) advice in Feb 2019. This was completed under the NICE program of Medical Innovation Briefing (MIB) to support new innovation through adoption.

See NICE website - https://bit.ly/2NzL9L8

"Resource impact could be less"

NICE have stated the ‘The resource impact may be less than standard care if surgical site complications are avoided’ and evidence shows that it could be cost saving vs standard of care.

This will support the adoption within the NHS to demonstrate the clear benefits of using Prevena™ to lower their Surgical Site Infection (SSI) rate. Supporting patient recovery and reduction in costs to the NHS system for those patients’ pathways.

Increasing SSI rates in the NHS

Between April 2013 and March 2018, the NHS completed a surveillance audit of SSIs across the participating NHS hospitals. There were 674,437 operations completed in the audit with an infection total of 7,890 (1.2%), with some of the highest infection rates of 8.7% / 6.7% for large and small bowel surgery.

Spend could be as high as £20,000 per patient if they get an SSI

As NICE referenced a cost per SSI to be in the region of £2,100 to £10,500, this could be between £16.5m to £82.8m cost to the NHS. In the same report from NICE, the expert opinion stated it could be higher, of between £14,000 to £20,000 per patient depending on complexity. However, from the “under the knife” report in 2011, looking at UK hospitals, the overall cost to the system was estimated at nearer £700m per annum.

Our services at Health Analytical Solutions Ltd, cover the full pathway of Med-Tech adoption. If you wish to read more about what we do and how we have helped other companies, please click the link below:

www.healthanalyticalsolutions.co.uk

We wish KCI all the success in the next step of the journey and look forward to hearing how the success has changed their market here in the UK and other countries.

#Medtech #Innovation #Infection #NICE

@acelity